Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
TELA Bio | TELA | Nov 22, 2024 | 3.01 | +4.15 |
Teladoc Health | TDOC | Nov 22, 2024 | 10.62 | +2.12 |
Telecom Argentina ADR | TEO | Nov 22, 2024 | 13.20 | +2.72 |
Telecom Services ETF Vanguard | VOX | Nov 22, 2024 | 153.03 | -0.06 |
Teledyne Technologies | TDY | Nov 22, 2024 | 483.69 | +0.72 |
Teleflex | TFX | Nov 22, 2024 | 191.71 | +0.56 |
Telefonica ADR | TEF | Nov 22, 2024 | 4.45 | +0.45 |
Telefonica Brasil ADR | VIV | Nov 22, 2024 | 8.75 | +0.46 |
Telephone And Data Systems | TDS | Nov 22, 2024 | 34.04 | +3.15 |
Telephone And Data Systems Pref | TDS-U | Nov 22, 2024 | 21.96 | -0.77 |
Telephone And Data Systems VV Pref | TDS-V | Nov 22, 2024 | 19.34 | -0.46 |
Telesat | TSAT | Nov 22, 2024 | 12.05 | +2.90 |
Telix Pharmaceuticals | TLX | Nov 22, 2024 | 14.70 | 0.00 |
Telomir Pharmaceuticals | TELO | Nov 22, 2024 | 4.24 | -5.15 |
Telos | TLS | Nov 22, 2024 | 3.25 | -2.11 |
Telus | TU | Nov 22, 2024 | 15.20 | -0.78 |
Telus International | TIXT | Nov 22, 2024 | 3.74 | +4.18 |
Tempest Therapeutics | TPST | Nov 22, 2024 | 0.91 | +1.33 |
Templeton Dragon Fund | TDF | Nov 22, 2024 | 8.34 | -2.46 |
Templeton Emerging Markets | TEI | Nov 22, 2024 | 5.32 | +0.19 |
Templeton Emerging Markets Fund | EMF | Nov 22, 2024 | 12.54 | +0.16 |
Tempur Sealy International | TPX | Nov 22, 2024 | 54.74 | +0.63 |
Tempus AI | TEM | Nov 22, 2024 | 58.60 | +11.66 |
Tenable | TENB | Nov 22, 2024 | 42.44 | +1.41 |
Tenaris ADR | TS | Nov 22, 2024 | 37.42 | +1.14 |
Tenax Therapeutics | TENX | Nov 22, 2024 | 4.92 | +1.44 |
Tenaya Therapeutics | TNYA | Nov 22, 2024 | 2.38 | +10.19 |
Tencent Music Entertainment A ADR | TME | Nov 22, 2024 | 11.53 | +0.09 |
Tenet Healthcare | THC | Nov 22, 2024 | 143.63 | -2.90 |
Tennant | TNC | Nov 22, 2024 | 89.69 | +2.05 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.